Localized Adverse Reaction to Administration of Drug Clinical Trial
Official title:
Cx621-0101 Phase I Clinical Trial in Healthy Volunteers to Evaluate the Feasibility and Safety of the Intralymphatic Administration Technique of Expanded Allogeneic Adipose-derived Stem Cells (eASCs)
The objective is to determine the safety, tolerability and feasibility of the inguinal intralymphatic administration of expanded allogeneic adipose-derived stem cells (eASCs)
Phase I, unicentric, single blind, clinical trial with healthy volunteers to determine the feasibility of a new administration technique. ;